335 related articles for article (PubMed ID: 15964347)
1. Therapy and prognosis of tumors of the genitourinary tract after kidney transplantation.
Diller R; Gruber A; Wolters H; Senninger N; Spiegel HU
Transplant Proc; 2005 Jun; 37(5):2089-92. PubMed ID: 15964347
[TBL] [Abstract][Full Text] [Related]
2. Genitourinary tumor following kidney transplantation: a multicenter study.
Einollahi B; Simforoosh N; Lessan-Pezeshki M; Basiri A; Nafar M; Pour-Reza Gholi F; Firouzan A; Ahmadpour P; Makhdomi K; Ghafari A; Taghizadeh A; Tayebi Khosroshahi H
Transplant Proc; 2009 Sep; 41(7):2848-9. PubMed ID: 19765454
[TBL] [Abstract][Full Text] [Related]
3. De novo renal cell carcinoma of native kidney in renal transplant recipients.
Neuzillet Y; Lay F; Luccioni A; Daniel L; Berland Y; Coulange C; Lechevallier E
Cancer; 2005 Jan; 103(2):251-7. PubMed ID: 15593084
[TBL] [Abstract][Full Text] [Related]
4. Superficial transitional cell carcinoma of the ureteral orifice: higher risk of developing subsequent upper urinary tract tumors.
Chou EC; Lin AT; Chen KK; Chang LS
Int J Urol; 2006 Jun; 13(6):682-5. PubMed ID: 16834642
[TBL] [Abstract][Full Text] [Related]
5. [Detection of urological and male genital tumors diagnosed in Beijing Hospital 1995 - 2004].
Liu M; Wang JY; Zhang YG; Zhu SC; Lu ZH; Wan B
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(34):2423-5. PubMed ID: 18036323
[TBL] [Abstract][Full Text] [Related]
6. [De novo urological neoplasms in kidney transplant patients: experience in 1,751 patients].
di Capua Sacoto C; Luján Marco S; Bahilo Mateu P; Budía Alba A; Pontones Moreno JL; Jiménez Cruz JF
Actas Urol Esp; 2010 Jan; 34(1):88-94. PubMed ID: 20223138
[TBL] [Abstract][Full Text] [Related]
7. The protective role of renal parenchyma as a barrier to local tumor spread of upper tract transitional cell carcinoma and its impact on patient survival.
Park J; Ha SH; Min GE; Song C; Hong B; Hong JH; Kim CS; Ahn H
J Urol; 2009 Sep; 182(3):894-9. PubMed ID: 19616243
[TBL] [Abstract][Full Text] [Related]
8. The impact factors on prognosis of patients with pT3 upper urinary tract transitional cell carcinoma.
Wu CF; Pang ST; Chen CS; Chuang CK; Chen Y; Lin PY
J Urol; 2007 Aug; 178(2):446-50, dicussion 450. PubMed ID: 17561129
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte subsets in renal transplant recipients with de novo genitourinary malignancies.
Guichard G; Rebibou JM; Ducloux D; Simula-Faivre D; Tiberghien P; Chalopin JM; Bittard H; Saas P; Kleinclauss F
Urol Int; 2008; 80(3):257-63. PubMed ID: 18480627
[TBL] [Abstract][Full Text] [Related]
10. CKD as a risk factor for bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma.
Chung SD; Huang KH; Lai MK; Huang CY; Chen CH; Pu YS; Yu HJ; Chueh SC
Am J Kidney Dis; 2007 Nov; 50(5):743-53. PubMed ID: 17954287
[TBL] [Abstract][Full Text] [Related]
11. Transitional cell carcinoma in renal transplant recipients: a single center experience.
Li XB; Xing NZ; Wang Y; Hu XP; Yin H; Zhang XD
Int J Urol; 2008 Jan; 15(1):53-7. PubMed ID: 18184173
[TBL] [Abstract][Full Text] [Related]
12. Urothelial cancer in patients with Endemic Balkan Nephropathy (EN) after renal transplantation.
Zivcić-Cosić S; Grzetić M; Valencić M; Oguić R; Maricić A; Dordević G; Balen S; Orlić L; Racki S; Fuckar Z
Ren Fail; 2007; 29(7):861-5. PubMed ID: 17994456
[TBL] [Abstract][Full Text] [Related]
13. Renal transplantation in patients with Balkan endemic nephropathy.
Basic-Jukic N; Hrsak-Puljic I; Kes P; Bubic-Filipi L; Pasini J; Hudolin T; Kastelan Z; Reiner Z; Kordic M; Brunetta B; Juric I
Transplant Proc; 2007 Jun; 39(5):1432-5. PubMed ID: 17580155
[TBL] [Abstract][Full Text] [Related]
14. [Statistics of genitourinary tumors at Mito Saiseikai Hospital].
Morozumi M; Sakamoto Y; Ogawa Y; Kitagawa R; Waku M
Hinyokika Kiyo; 1985 Sep; 31(9):1589-92. PubMed ID: 4083216
[TBL] [Abstract][Full Text] [Related]
15. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.
Huguet J; Crego M; Sabaté S; Salvador J; Palou J; Villavicencio H
Eur Urol; 2005 Jul; 48(1):53-9; discussion 59. PubMed ID: 15967252
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract.
Terakawa T; Miyake H; Muramaki M; Takenaka A; Hara I; Fujisawa M
Urology; 2008 Jan; 71(1):123-7. PubMed ID: 18242379
[TBL] [Abstract][Full Text] [Related]
17. Urological malignancy as a complication of renal transplantation: a report of twelve clinical cases.
Zhou M; Zhu Y; Wang L; Wang Y; Fu S; Min Z
Clin Transpl; 2006; ():395-8. PubMed ID: 18365395
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous metastases from genitourinary malignancies.
Mueller TJ; Wu H; Greenberg RE; Hudes G; Topham N; Lessin SR; Uzzo RG
Urology; 2004 Jun; 63(6):1021-6. PubMed ID: 15183939
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma in renal transplant recipients.
Chuang CH; Chien YS; Cheng YT; Chen YT; Hu TH; Hsieh H
Transplant Proc; 2008 Sep; 40(7):2392-4. PubMed ID: 18790244
[TBL] [Abstract][Full Text] [Related]
20. The role of microscopic hematuria in the evaluation of urologic malignancy in renal transplant recipients.
Kim DY; Abouljoud M; Parasuraman R
Transplant Proc; 2010 Jun; 42(5):1641-2. PubMed ID: 20620491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
